精子微小RNA配对:寻找男性生育力生物标志物的新视角
本研究重新分析既往已发表研究中通过TaqMan定量聚合酶链反应(PCR)检测的生育力正常与不育个体736个精子微小RNA的表达数据,筛选在生育力正常者中表达相关、在各不育组中不相关的微小RNA配对,并在独立队列中用实时定量PCR验证。结果显示hsa-miR-942-5p/hsa-miR-1208与hsa-miR-34b-3p/hsa-miR-93-3p等配对具有成为诊断男性不育的新分子生物标志物的潜力。
要点
- 在生育力正常组中筛出48对表达显著相关的精子微小RNA配对。
- hsa-miR-942-5p/hsa-miR-1208在验证队列中检出精液异常的真阳性率为85.71%。
- 作者认为hsa-miR-942-5p/hsa-miR-1208和hsa-miR-34b-3p/hsa-miR-93-3p配对有潜力成为诊断男性不育的新分子生物标志物。
核心结论
- hsa-miR-942-5p/hsa-miR-1208和hsa-miR-34b-3p/hsa-miR-93-3p配对有潜力成为帮助诊断男性不育的新分子生物标志物,尤其在不明原因男性不育或精液参数接近阈值时。
研究设计与样本
- 重新分析既往已发表研究中通过TaqMan定量聚合酶链反应(PCR)检测的生育力正常与不育个体736个精子微小RNA的表达数据,筛选最佳生物标志物潜力的微小RNA配对,并在独立队列中用实时定量PCR(qRT-PCR)验证。
- 研究场所为大学实验室;精液样本来自生育力正常者(n=10)和不育者(弱精子症n=10、畸形精子症n=10、少精子症n=10、不明原因男性不育n=8);验证队列包括9名生育力正常供者和14例伴不同精液异常的不育患者。
主要发现
- 48对微小RNA在生育力正常组中显示显著相关。
- 在不育人群中不相关且生物标志物潜力最佳的配对为:弱精子症hsa-miR-942-5p/hsa-miR-1208、畸形精子症hsa-miR-296-5p/hsa-miR-328-3p、少精子症hsa-miR-139-5p/hsa-miR-1260a、不明原因男性不育hsa-miR-34b-3p/hsa-miR-93-3p。
- hsa-miR-942-5p/hsa-miR-1208配对在验证队列中检测精液异常显示出最大潜力,真阳性率为85.71%。
关键数值与推荐
- 采用Spearman检验筛选在生育力正常个体中表达相关、在各不育组中表达不相关的微小RNA配对。
- 采用受试者工作特征曲线确定配对的生物标志物潜力,并用Mann-Whitney检验验证各配对在生育力正常与不育人群中的相对表达差异。
- 最佳结果配对通过qRT-PCR验证。
临床怎么用
- 作者认为hsa-miR-942-5p/hsa-miR-1208和hsa-miR-34b-3p/hsa-miR-93-3p配对有潜力成为帮助诊断男性不育的新分子生物标志物,尤其在不明原因男性不育或精液参数接近阈值时。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify candidates of fertility biomarkers among pairs of human sperm microRNAs. DESIGN: Expression data of 736 sperm microRNAs from fertile and infertile individuals characterized in previous published studies by means of TaqMan quantitative polymerase chain reaction (PCR) were reexamined. A set of microRNA pairs with the best biomarker potential were selected and validated by means of quantitative real-time (qRT) PCR in an independent cohort. SETTING: University laboratory. PATIENT(S): Semen samples were obtained from fertile (n = 10) and infertile (asthenozoospermia, n = 10; teratozoospermia, n = 10; oligozoospermia, n = 10; unexplained male infertility [UMI], n = 8) individuals. The validation cohort included 9 fertile donors and 14 infertile patients with different seminal alterations. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Spearman test was used to select microRNA pairs with a correlated expression in fertile individuals and a noncorrelated expression in each infertile group. The biomarker potential of these pairs was determined with the use of receiver operating characteristic curves. The differential relative expression of each pair in fertile and infertile populations was verified (Mann-Whitney test). Those pairs with best results were validated by qRT-PCR. RESULT(S): Forty-eight pairs showed significant correlations in the fertile group. The pairs that were uncorrelated in the infertile populations and displayed the best biomarker potential were hsa-miR-942-5p/hsa-miR-1208 (asthenozoospermia), hsa-miR-296-5p/hsa-miR-328-3p (teratozoospermia), hsa-miR-139-5p/hsa-miR-1260a (oligozoospermia), and hsa-miR-34b-3p/hsa-miR-93-3p (UMI). The hsa-miR-942-5p/hsa-miR-1208 pair showed the greatest potential for detecting seminal alterations in the validation cohort (85.71% true positives). CONCLUSION(S): The pairs hsa-miR-942-5p/hsa-miR-1208 and hsa-miR-34b-3p/hsa-miR-93-3p have the potential to become new molecular biomarkers that could help to diagnose male infertility, especially in cases of UMI or when seminal parameters are close to the threshold values.
引用
- Corral-Vazquez C, Salas-Huetos A, Blanco J, et al. Sperm microRNA pairs: new perspectives in the search for male fertility biomarkers. Fertil Steril. 2019. PMID: 31587805. doi:10.1016/j.fertnstert.2019.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。